Related Experiment Video
Updated: Jun 7, 2025
15:43
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
22.7K
Pseudomonas Labyrinthitis Complicating Acute Otitis Media: Case Report
Ghada Kharrat1,2, Sana Ferchichi1,2, Zahra Jouini1
1ENT Department, Mohamed Taher Mâamouri University Hospital, Nabeul, Tunisia.
Ear, Nose, & Throat Journal
|November 14, 2024
Summary
This case report details an 18-year-old female with sudden hearing loss and vertigo caused by Pseudomonas aeruginosa labyrinthitis. While treatment resolved dizziness, hearing loss persisted, highlighting the challenges of this rare infection.
Area of Science:
- Otolaryngology
- Infectious Diseases
- Neuroscience
Background:
- Bacterial labyrinthitis is a rare condition, with Pseudomonas involvement being exceptionally uncommon.
- This case highlights the diagnostic and therapeutic challenges associated with bacterial labyrinthitis.
Purpose of the Study:
- To present a rare case of Pseudomonas aeruginosa labyrinthitis.
- To discuss the diagnostic modalities, particularly the role of imaging.
- To review treatment strategies and prognosis for this condition.
Main Methods:
- A case report of an 18-year-old female with acute otitis media followed by labyrinthitis symptoms.
- Diagnostic tools included otoendoscopy, audiometry, temporal bone CT, and MRI with CISS sequence.
- Treatment involved intravenous antibiotics, corticosteroids, vestibular rehabilitation, and hyperbaric oxygen therapy.
Main Results:
- Pseudomonas aeruginosa was isolated from otorrhea.
- MRI with CISS sequence revealed intense labyrinthine enhancement, aiding diagnosis.
- The patient's dizziness resolved, but sensorineural hearing loss remained.
Conclusions:
- Pseudomonas aeruginosa is an exceptional pathogen in bacterial labyrinthitis.
- Magnetic resonance imaging (MRI) is crucial for diagnosing labyrinthitis and differentiating it from other conditions.
- Despite treatment, hearing loss may persist, indicating a guarded prognosis for auditory function.
Related Concept Videos
01:30Pneumonia I: Introduction
211
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
211
01:30Pneumonia III: Complications and Assessment
170
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
170
01:28Pneumonia IV: Management
299
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
299